000 | 01236 a2200313 4500 | ||
---|---|---|---|
005 | 20250514004126.0 | ||
264 | 0 | _c20010809 | |
008 | 200108s 0 0 eng d | ||
022 | _a1520-9156 | ||
024 | 7 |
_a10.1089/152091599316775 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aThrailkill, K M | |
245 | 0 | 0 |
_aInsulin-like growth factor-I in diabetes mellitus: its physiology, metabolic effects, and potential clinical utility. _h[electronic resource] |
260 |
_bDiabetes technology & therapeutics _c2000 |
||
300 |
_a69-80 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aDiabetes Mellitus _xdrug therapy |
650 | 0 | 4 |
_aDiabetic Nephropathies _xetiology |
650 | 0 | 4 |
_aDiabetic Neuropathies _xetiology |
650 | 0 | 4 |
_aDiabetic Retinopathy _xetiology |
650 | 0 | 4 | _aHomeostasis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInsulin Resistance |
650 | 0 | 4 |
_aInsulin-Like Growth Factor Binding Proteins _xphysiology |
650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xphysiology |
650 | 0 | 4 |
_aIslets of Langerhans _xphysiopathology |
773 | 0 |
_tDiabetes technology & therapeutics _gvol. 2 _gno. 1 _gp. 69-80 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1089/152091599316775 _zAvailable from publisher's website |
999 |
_c11395047 _d11395047 |